INM financials
InMed Pharmaceuticals (INM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
INM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | – | – | – | -$12.99M | -3.12 |
| 2025 | $4.94M | $1.71M | – | -$8.16M | -8.36 |
| 2024 | $4.60M | $1.10M | – | -$7.68M | -20.14 |
| 2023 | $4.14M | $1.40M | – | -$7.95M | -65.00 |
| 2022 | $1.09M | $543.55K | – | -$18.60M | -663.40 |
| 2021 | – | – | – | -$10.20M | -759.20 |